Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13135 | 858 | 35.9 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
2245 | 2 | HAIRY CELL LEUKEMIA//CLADRIBINE//2 CHLORODEOXYADENOSINE | 4716 |
13135 | 1 | CLOFARABINE//CLADRIBINE//2 CHLORODEOXYADENOSINE | 858 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CLOFARABINE | authKW | 1772045 | 10% | 57% | 87 |
2 | CLADRIBINE | authKW | 1568117 | 15% | 35% | 127 |
3 | 2 CHLORODEOXYADENOSINE | authKW | 1087172 | 8% | 43% | 71 |
4 | 2 CHLORO 2 DEOXYADENOSINE | authKW | 695058 | 3% | 78% | 25 |
5 | NELARABINE | authKW | 553685 | 3% | 68% | 23 |
6 | 2 CDA | authKW | 514201 | 4% | 43% | 34 |
7 | FLUDARABINE | authKW | 469687 | 12% | 12% | 106 |
8 | FLUDARABINE PHOSPHATE | authKW | 268262 | 2% | 54% | 14 |
9 | ARA G | authKW | 253065 | 1% | 89% | 8 |
10 | 2 CHLOROADENINE | authKW | 148280 | 1% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 7962 | 30% | 0% | 254 |
2 | Oncology | 7308 | 48% | 0% | 410 |
3 | Pharmacology & Pharmacy | 689 | 19% | 0% | 159 |
4 | Medicine, Research & Experimental | 32 | 3% | 0% | 30 |
5 | Transplantation | 24 | 2% | 0% | 13 |
6 | Chemistry, Medicinal | 19 | 2% | 0% | 19 |
7 | Chemistry, Analytical | 12 | 3% | 0% | 28 |
8 | Biochemistry & Molecular Biology | 12 | 8% | 0% | 71 |
9 | Biochemical Research Methods | 11 | 2% | 0% | 19 |
10 | Rheumatology | 10 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMORAL METAB UNIT | 64055 | 0% | 60% | 3 |
2 | EXPT CYTOL UNIT | 40032 | 0% | 38% | 3 |
3 | ALWPEBMT PARIS OFFUMR S | 35588 | 0% | 100% | 1 |
4 | BIOCHEM PHARMACOL PRECLIN PHARMACOL | 35588 | 0% | 100% | 1 |
5 | BREAST HEAD NECK | 35588 | 0% | 100% | 1 |
6 | CANC HIGH PLAINS | 35588 | 0% | 100% | 1 |
7 | CANC MALIGNANCIES PROGRAM | 35588 | 0% | 100% | 1 |
8 | CHILDRENS LEUKEAEMIA CANC | 35588 | 0% | 100% | 1 |
9 | CLIN RADIAT BIOL RADIAT PHYS | 35588 | 0% | 100% | 1 |
10 | CLIN UNIVERSITAI | 35588 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUKEMIA & LYMPHOMA | 15193 | 7% | 1% | 57 |
2 | HEMATOLOGY AND CELL THERAPY | 4553 | 1% | 3% | 5 |
3 | ANNALS OF HEMATOLOGY | 3474 | 2% | 1% | 19 |
4 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2533 | 3% | 0% | 23 |
5 | INVESTIGATIONAL NEW DRUGS | 2336 | 2% | 1% | 13 |
6 | SEMINARS IN HEMATOLOGY | 2249 | 1% | 1% | 11 |
7 | JOURNAL OF CLINICAL ONCOLOGY | 2207 | 4% | 0% | 32 |
8 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2179 | 2% | 0% | 17 |
9 | LEUKEMIA | 2048 | 2% | 0% | 21 |
10 | CANCER TREATMENT REPORTS | 1598 | 1% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLOFARABINE | 1772045 | 10% | 57% | 87 | Search CLOFARABINE | Search CLOFARABINE |
2 | CLADRIBINE | 1568117 | 15% | 35% | 127 | Search CLADRIBINE | Search CLADRIBINE |
3 | 2 CHLORODEOXYADENOSINE | 1087172 | 8% | 43% | 71 | Search 2+CHLORODEOXYADENOSINE | Search 2+CHLORODEOXYADENOSINE |
4 | 2 CHLORO 2 DEOXYADENOSINE | 695058 | 3% | 78% | 25 | Search 2+CHLORO+2+DEOXYADENOSINE | Search 2+CHLORO+2+DEOXYADENOSINE |
5 | NELARABINE | 553685 | 3% | 68% | 23 | Search NELARABINE | Search NELARABINE |
6 | 2 CDA | 514201 | 4% | 43% | 34 | Search 2+CDA | Search 2+CDA |
7 | FLUDARABINE | 469687 | 12% | 12% | 106 | Search FLUDARABINE | Search FLUDARABINE |
8 | FLUDARABINE PHOSPHATE | 268262 | 2% | 54% | 14 | Search FLUDARABINE+PHOSPHATE | Search FLUDARABINE+PHOSPHATE |
9 | ARA G | 253065 | 1% | 89% | 8 | Search ARA+G | Search ARA+G |
10 | 2 CHLOROADENINE | 148280 | 1% | 83% | 5 | Search 2+CHLOROADENINE | Search 2+CHLOROADENINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHENCHUK, A , LOTFI, K , JULIUSSON, G , ALBERTIONI, F , (2009) MECHANISMS OF ANTI-CANCER ACTION AND PHARMACOLOGY OF CLOFARABINE.BIOCHEMICAL PHARMACOLOGY. VOL. 78. ISSUE 11. P. 1351 -1359 | 46 | 82% | 47 |
2 | SIGAL, DS , MILLER, HJ , SCHRAM, ED , SAVEN, A , (2010) BEYOND HAIRY CELL: THE ACTIVITY OF CLADRIBINE IN OTHER HEMATOLOGIC MALIGNANCIES.BLOOD. VOL. 116. ISSUE 16. P. 2884 -2896 | 65 | 59% | 17 |
3 | ROBAK, T , KORYCKA, A , ROBAK, E , (2006) OLDER AND NEW FORMULATIONS OF CLADRIBINE. PHARMACOLOGY AND CLINICAL EFFICACY IN HEMATOLOGICAL MALIGNANCIES.RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY. VOL. 1. ISSUE 1. P. 23-38 | 74 | 57% | 6 |
4 | GANDHI, V , PLUNKETT, W , (2006) CLOFARABINE AND NELARABINE: TWO NEW PURINE NUCLEOSIDE ANALOGS.CURRENT OPINION IN ONCOLOGY. VOL. 18. ISSUE 6. P. 584-590 | 43 | 86% | 20 |
5 | ROBAK, T , LECH-MARANDA, E , KORYCKA, A , ROBAK, E , (2006) PURINE NUCLEOSIDE ANALOGS AS IMMUNOSUPPRESSIVE AND ANTINEOPLASTIC AGENTS: MECHANISM OF ACTION AND, CLINICAL ACTIVITY.CURRENT MEDICINAL CHEMISTRY. VOL. 13. ISSUE 26. P. 3165-3189 | 83 | 39% | 71 |
6 | ROBAK, T , KORYCKA, A , LECH-MARANDA, E , ROBAK, P , (2009) CURRENT STATUS OF OLDER AND NEW PURINE NUCLEOSIDE ANALOGUES IN THE TREATMENT OF LYMPHOPROLIFERATIVE DISEASES.MOLECULES. VOL. 14. ISSUE 3. P. 1183 -1226 | 74 | 41% | 35 |
7 | SIGAL, DS , SAVEN, A , (2008) CLADRIBINE IN INDOLENT NON-HODGKIN'S LYMPHOMA.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 8. ISSUE 4. P. 535 -545 | 48 | 61% | 6 |
8 | ROBAK, T , (2001) CLADRIBINE IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA.LEUKEMIA & LYMPHOMA. VOL. 40. ISSUE 5-6. P. 551 -564 | 54 | 61% | 24 |
9 | HENTOSH, P , PEFFLEY, DM , (2010) THE CLADRIBINE CONUNDRUM: DECIPHERING THE DRUG'S MECHANISM OF ACTION.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 6. ISSUE 1. P. 75-81 | 40 | 65% | 5 |
10 | ROBAK, P , ROBAK, T , (2013) OLDER AND NEW PURINE NUCLEOSIDE ANALOGS FOR PATIENTS WITH ACUTE LEUKEMIAS.CANCER TREATMENT REVIEWS. VOL. 39. ISSUE 8. P. 851-861 | 48 | 41% | 33 |
Classes with closest relation at Level 1 |